CRISPR Therapeutics to Participate Upcoming Investor Conferences

ZUG, Switzerland and CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in fireside chats at the following investor conferences in May.

Bank of America Securities 2023 Health Care ConferenceDate: Tuesday, May 9, 2023Time: 10:40 a.m. PT

JMP Securities Life Sciences ConferenceDate: Monday, May 15, 2023Time: 11:30 a.m. ET

A live webcast of the fireside chats will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the webcasts will be archived on the Company's website for 14 days following the presentation.

About CRISPR Therapeutics

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations in Boston, Massachusetts and San Francisco, California, and business offices in London, United Kingdom. For more information, please visit www.crisprtx.com.

Investor Contact:Susan Kim+1-617-307-7503[email protected]

Media Contact:Rachel Eides +1-617-315-4493[email protected]

You May Also Be Interested In

• Slew of analyst comments sends Take-Two (TTWO) up 4% ahead of November earnings and GTV 6
• Black Diamond Group Limited to Announce Third Quarter 2026 Financial Results and Host Conference Call
• Solera | Hollander Showcases the Next Era of Automotive Recycling at ARA 2026